CRMD
Price
$9.13
Change
+$0.68 (+8.05%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
554.05M
14 days until earnings call
RLYB
Price
$0.30
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:13 PM (EDT)
Capitalization
12.38M
19 days until earnings call
Ad is loading...

CRMD vs RLYB

Header iconCRMD vs RLYB Comparison
Open Charts CRMD vs RLYBBanner chart's image
CorMedix
Price$9.13
Change+$0.68 (+8.05%)
Volume$29.96K
Capitalization554.05M
Rallybio
Price$0.30
Change-$0.00 (-0.00%)
Volume$100
Capitalization12.38M
CRMD vs RLYB Comparison Chart
Loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRMD vs. RLYB commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMD is a Buy and RLYB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CRMD: $8.44 vs. RLYB: $0.30)
Brand notoriety: CRMD and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRMD: 74% vs. RLYB: 127%
Market capitalization -- CRMD: $554.05M vs. RLYB: $12.38M
CRMD [@Biotechnology] is valued at $554.05M. RLYB’s [@Biotechnology] market capitalization is $12.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRMD’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • CRMD’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than CRMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRMD’s TA Score shows that 5 TA indicator(s) are bullish while RLYB’s TA Score has 6 bullish TA indicator(s).

  • CRMD’s TA Score: 5 bullish, 3 bearish.
  • RLYB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than CRMD.

Price Growth

CRMD (@Biotechnology) experienced а +12.30% price change this week, while RLYB (@Biotechnology) price change was +18.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

CRMD is expected to report earnings on Aug 07, 2025.

RLYB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRMD($554M) has a higher market cap than RLYB($12.4M). CRMD YTD gains are higher at: 4.259 vs. RLYB (-69.000). CRMD has higher annual earnings (EBITDA): -47.32M vs. RLYB (-60.37M). RLYB has more cash in the bank: 65.5M vs. CRMD (46M). RLYB has less debt than CRMD: RLYB (154K) vs CRMD (556K). CRMD has higher revenues than RLYB: CRMD (12.3M) vs RLYB (636K).
CRMDRLYBCRMD / RLYB
Capitalization554M12.4M4,468%
EBITDA-47.32M-60.37M78%
Gain YTD4.259-69.000-6%
P/E RatioN/AN/A-
Revenue12.3M636K1,934%
Total Cash46M65.5M70%
Total Debt556K154K361%
FUNDAMENTALS RATINGS
CRMD: Fundamental Ratings
CRMD
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRMDRLYB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCLIX46.52N/A
N/A
Fidelity Advisor Industrials I
PQIAX36.70N/A
N/A
Principal Equity Income A
DWGFX10.92N/A
N/A
American Funds Dvlpg Wld Gr&Inc F1
TANDX36.37N/A
N/A
Castle Tandem No-Load
WBGSX7.24N/A
N/A
William Blair Growth N

CRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRMD has been loosely correlated with MURA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CRMD jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMD
1D Price
Change %
CRMD100%
-0.65%
MURA - CRMD
41%
Loosely correlated
+1.84%
ARTL - CRMD
33%
Poorly correlated
-11.16%
RLYB - CRMD
32%
Poorly correlated
+4.79%
DNLI - CRMD
32%
Poorly correlated
+1.85%
XLO - CRMD
31%
Poorly correlated
-1.23%
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PXXLF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
+4.79%
PXXLF - RLYB
44%
Loosely correlated
N/A
ELVN - RLYB
42%
Loosely correlated
-1.45%
ATXS - RLYB
41%
Loosely correlated
+12.55%
PRME - RLYB
40%
Loosely correlated
+4.14%
SLNO - RLYB
38%
Loosely correlated
+1.22%
More